29.10.2014 Views

Download - WHOCC

Download - WHOCC

Download - WHOCC

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

QC<br />

CARDIOVASCULAR SYSTEM<br />

QC01<br />

QC01A<br />

CARDIAC THERAPY<br />

CARDIAC GLYCOSIDES<br />

Plain and combined preparations containing cardiac glycosides, including<br />

standardized herbal extracts, are classified in this group.<br />

QC01AA<br />

Digitalis glycosides<br />

Combinations with diuretics are classified here<br />

QC01AB<br />

QC01AC<br />

QC01AX<br />

Scilla glycosides<br />

Strophantus glycosides<br />

Other cardiac glycosides<br />

QC01B<br />

ANTIARRHYTHMICS, CLASS I AND III<br />

Preparations used in the treatment of arrhythmias should be classified in this<br />

group. See also QC08 - Calcium channel blockers.<br />

As in the ATC system, agents are listed according to the Vaughan Williams<br />

classification of antiarrhythmics. The division of class I antiarrhythmics may<br />

vary, depending on the literature used. The 3rd ed. of Avery’s Drug Treatment<br />

(1987) and Drugs 31, 93 - 95, 1986 have been used as a basis for the ATC<br />

classification.<br />

Class II antiarrhytmics are assigned to group QC07 - Beta blocking agents, and<br />

class IV antiarrhythmics to QC08 - Calcium channel blockers.<br />

Combined preparations are classified at separate 5th levels using the<br />

corresponding 50-series codes or, if not available, using the 5th level code 99.<br />

47

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!